Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Getting Radical About Obesity

New Links Between Fat and Heart Disease

Matthias Barton, Elvira Haas, Indranil Bhattacharya
Download PDF
https://doi.org/10.1161/ATVBAHA.108.181529
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:447-448
Originally published March 18, 2009
Matthias Barton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elvira Haas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Indranil Bhattacharya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Visceral obesity has become the most frequent preventable condition accounting for diseases such as hypertension and diabetes, two of the major risk factors for coronary artery disease, stroke, and chronic renal failure.1–3 Despite the awareness aiming to reduce the prevalence of obesity, the number of obese patients continues to rise and now includes even developing countries, and increasingly children are affected.4,5 In fact, if this trend continues, 26 million children in Europe will be overweight or obese by the year 2010, rising by approximately 1.3 million per year.5,6 The annual health costs related to obesity have been estimated close to 100 billion USD in the United States,7,8 illustrating the enormous economic burden the disease obesity carries.

See accompanying article in ATVB 2009;29:239–245.

What are the mechanisms contributing to the high cardiovascular risk brought about by obesity? Obesity is a low-grade inflammatory condition9 and typically characterized by increase in visceral adipose tissue. Visceral fat is both a source and target of inflammatory cytokines and growth factors, which directly may affect preadipocyte differentiation via signaling cascades implicated in cell growth such as Ras-Raf-ERK-1/2.10 Adipose tissue also contains inflammatory cells, including cytokine-producing macrophages.9 In addition, adipocytes express a fully functional NADPH oxidase system maintaining local production of reactive oxygen species,11 which in turn either work as signaling molecules or further stimulate production of growth factors implicated in adipogenesis.12,13 Previous work has investigated effects of preadipocyte differentiation on expression of Nox4,14 a component of the vascular NADPH oxidase, and Mahadev et al demonstrated that Nox4—via H2O2—regulates insulin-mediated phosphorylation of the insulin receptor and its substrate, insulin receptor substrate (IRS)-1.15 However, whether Nox4 actively takes part in adipogenesis has remained unknown.

In the present issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Schröder and coworkers now provide us with a new mechanism by which Nox4 controls preadipocyte differentiation.16 These investigators found that Nox4 represents the switch between insulin-induced proliferation of preadipocytes and differentiation through activation of MAPK phosphatase-1 (MKP-1). Insulin lowers not only blood glucose by facilitating its uptake into target tissues, but is also an important regulator of adipogenesis. Schröder et al further show that insulin-mediated differentiation of preadipocytes depends on the formation of H2O2, likely derived from Nox4, either directly or through conversion from superoxide anion.17 Silencing of Nox4 gene expression attenuated insulin-induced H2O2 production. A causal role of H2O2 was further confirmed by overexpressing or supplementing cells with catalase, both of which blocked preadipocyte differentiation. Overexpression of Nox4 reduced ERK-1/2 phosphorylation and serine phosphorylation of IRS-1, which was accompanied by a concomitant increase in tyrosine phosphorylation of IRS-1, thereby promoting metabolic insulin signaling. The authors further demonstrate that regulation of MKP-1, which is known to dephosphorylate ERK-1/2,18 was dependent on Nox4. Overexpression of Nox4 is associated with a parallel increase in MKP-1 expression, resulting in insulin-mediated differentiation of preadipocytes (Figure). Taken together, this study importantly links Nox4-derived H2O2 to the differentiation of preadipocytes into adipocytes, even in the absence of insulin. Given the high prevalence of vascular and renal disease in obese patients,1 the present work raises the question whether Nox4 also levels modulate adipose tissue homeostasis in vivo.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Proposed role of Nox4 acting as a switch between preadipocyte differentiation and proliferation. In healthy adipose tissue (left panel), the expression/activity of Nox4 (green) in the preadipocytes is maintained at low level which regulates the expression of MKP-1 (blue) involving the generation of reactive oxygen species. Under these conditions, insulin receptor stimulation results in ERK1/2-induced serine phosphorylation (S-p) of IRS-1 (pink), which blocks IRS-1 tyrosine phosphorylation (Y-p) thereby promoting basal andiocytes proliferation. However in obesity (right panel), when the expression/activity of Nox4 (green) increases in preadipocytes. There is a parallel increase in the expression/activity of MKP-1 (blue) which blocks ERK1/2-mediated IRS-1 serine phosphorylation thus facilitating tyrosine phosphorylation of IRS-1. Eventually, the balance is shifted toward differentiation of preadipocytes, with a consecutive decrease in proliferation. This mechanism appears functional even in the absence of insulin.

Interestingly, the authors also report difficulties associated with RNA silencing, as they found that although nine probes were claimed to be specific by the manufacturer, several of the siRNA used also blocked other Nox isoforms, and only 1 out of 9 was specific for Nox4.16 According to siRNA manufacturers, siRNA technology is not entirely specific for the genes of interest, and standard siRNA may silence multiple genes unrelated to the gene of interest or have unspecific effects.16,19–21 New developments in RNA silencing may help to reduce this problem. Therefore, the work by Schröder et al is one more piece adding to the puzzle that seemingly specific new technology often comes with unexpected limitations.20,21

Nox4-derived reactive oxygen species have been implicated in coronary heart disease, hypertension, and renal failure, mainly because of the detrimental effects of excessively high levels of reactive oxygen species.22–24 Whether known activators of Nox4, such as the renin–angiotensin system17 which becomes activated during obesity,25 also cause preadipocytes to differentiate and thereby stimulate obesity development is a tempting hypothesis and would by supported by the work of Schröder et al.16 One therefore might ask the question whether drugs known to inhibit NADPH oxidase such as statins or angiotensin receptor blockers affect preadipocyte differentiation and proliferation. The latter has been shown by Mori and associates,26 and it appears that the work by Schröder et al has succeeded to provide us with one important missing link that might explain these previous observations.26

Despite all the advances in research we should keep in mind that abdominal obesity, the visually apparent consequence of visceral preadipocyte differentiation, continues to be a major health issue around the world affecting both adults and children.1–6 Should we fail to get radical about obesity in time, today’s children might not live up to our expectations.27

Acknowledgments

The authors thank Dr Matthias Saur for critical reading of the manuscript.

Sources of Funding

This work was supported by grants of the Swiss National Science Foundation (3200-108258/1 and K-33KO122504/1), and by the University of Zurich.

Disclosures

None.

References

  1. ↵
    Barton M, Furrer J. Cardiovascular consequences of the obesity pandemic: need for action. Expert Opin Investig Drugs. 2003; 12: 1757–1759.
    OpenUrlCrossRefPubMed
  2. ↵
    Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002; 23: 706–713.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001; 154: 497–504.
    OpenUrlCrossRefPubMed
  4. ↵
    Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002; 40: 441–447.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Kosti RI, Panagiotakos DB. The epidemic of obesity in children and adolescents in the world. Cent Eur J Public Health. 2006; 14: 151–159.
    OpenUrlPubMed
  6. ↵
    Jackson-Leach R, Lobstein T. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. Int J Pediatr Obes. 2006; 1: 26–32.
    OpenUrlCrossRefPubMed
  7. ↵
    Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res. 2004; 12: 18–24.
    OpenUrlCrossRefPubMed
  8. ↵
    Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who’s paying? Health Aff (Millwood). 2003; Suppl Web Exclusives: W3–219–226.
    OpenUrl
  9. ↵
    Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003; 112: 1785–1788.
    OpenUrlCrossRefPubMed
  10. ↵
    Porras A, Alvarez AM, Valladares A, Benito M. p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes. Mol Endocrinol. 1998; 12: 825–834.
    OpenUrlCrossRefPubMed
  11. ↵
    Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752–1761.
    OpenUrlCrossRefPubMed
  12. ↵
    Kahler J, Mendel S, Weckmuller J, Orzechowski HD, Mittmann C, Koster R, Paul M, Meinertz T, Munzel T. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol. 2000; 32: 1429–1437.
    OpenUrlCrossRefPubMed
  13. ↵
    Bhattacharya I, Ullrich A. Endothelin-1 inhibits adipogenesis: role of phosphorylation of Akt and ERK1/2. FEBS Lett. 2006; 580: 5765–5771.
    OpenUrlCrossRefPubMed
  14. ↵
    Mouche S, Mkaddem SB, Wang W, Katic M, Tseng YH, Carnesecchi S, Steger K, Foti M, Meier CA, Muzzin P, Kahn CR, Ogier-Denis E, Szanto I. Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation. Biochim Biophys Acta. 2007; 1773: 1015–1027.
    OpenUrlPubMed
  15. ↵
    Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, Lambeth JD, Goldstein BJ. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 2004; 24: 1844–1854.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Schroder K, Wandzioch K, Helmcke I. Brandes RP. Nox4 Acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol. 2009; 29: 239–245.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87: 245–313.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993; 75: 487–493.
    OpenUrlCrossRefPubMed
  19. ↵
    Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther. 2007; 9: 248–257.
    OpenUrlPubMed
  20. ↵
    Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Kariko K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008; 452: 591–597.
    OpenUrlCrossRefPubMed
  21. ↵
    Kalluri R, Kanasaki K. RNA interference: generic block on angiogenesis. Nature. 2008; 452: 543–545.
    OpenUrlCrossRefPubMed
  22. ↵
    Griendling KK, Harrison DG. Out, damned dot: studies of the NADPH oxidase in atherosclerosis. J Clin Invest. 2001; 108: 1423–1424.
    OpenUrlCrossRefPubMed
  23. ↵
    Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008; 31 Suppl 2: S170–S180.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002; 105: 1429–1435.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, Hillen H, Haudenschild CC, Krieger JE, Munter K, Lattmann T, Luscher TF, Shaw S. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension. 2000; 35: 329–336.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Mori Y, Itoh Y, Tajima N. Angiotensin II receptor blockers downsize andiocytes in spontaneously type 2 diabetic rats with visceral fat obesity. Am J Hypertens. 2007; 20: 431–436.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005; 352: 1138–1145.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
April 2009, Volume 29, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Getting Radical About Obesity
    Matthias Barton, Elvira Haas and Indranil Bhattacharya
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:447-448, originally published March 18, 2009
    https://doi.org/10.1161/ATVBAHA.108.181529

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Getting Radical About Obesity
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Getting Radical About Obesity
    Matthias Barton, Elvira Haas and Indranil Bhattacharya
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:447-448, originally published March 18, 2009
    https://doi.org/10.1161/ATVBAHA.108.181529
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • Instructions for Authors
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured